Antimicrobial resistance in major pathogens of hospital-acquired pneumonia in Asian countries

American Journal of Infection Control

Volumn 36, Issue 4 SUPPL., 2008, Pages

  Lagamayo, Evelina N ^a  

^a UNIVERSITY OF SANTO TOMAS   (Philippines)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFOPERAZONE; CEFOXITIN; CEFPIROME; CEFPODOXIME; CEFTAZIDIME; CEPHALOSPORIN; CIPROFLOXACIN; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULPERAZON;

ACINETOBACTER; ANTIBIOTIC RESISTANCE; ARTICLE; ASIA; CONSENSUS DEVELOPMENT; COST EFFECTIVENESS ANALYSIS; DEVELOPING COUNTRY; ESCHERICHIA COLI; HEALTH CARE DELIVERY; HOSPITAL ACQUIRED PNEUMONIA; HOSPITAL INFECTION; HUMAN; INCIDENCE; KLEBSIELLA PNEUMONIAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANCE; PRACTICE GUIDELINE; PREVALENCE; PSEUDOMONAS AERUGINOSA; STRAIN IDENTIFICATION; TREATMENT OUTCOME; VENTILATOR ASSOCIATED PNEUMONIA;

ASIA; COMMUNICABLE DISEASES, EMERGING; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; INCIDENCE; PNEUMONIA, VENTILATOR-ASSOCIATED;

EID: 43049120324     PISSN: 01966553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajic.2007.10.020     Document Type: Article

References (43)

1. Prashanth K., and Badrinath S. Epidemiological investigation of nosocomial Acinetobacter infections using arbitrarily primed PCR and pulse-field gel electrophoresis. Indian J Med Res 122 (2005) 408-418
2. Lee K., Yum J.H., Yong D., Lee H.M., Kim H.D., Docquier J.D., et al. Novel acquired metallo-β-lactamase gene, bla(SIM-1), in a class 1 integron from Acinetobacter baumannii clinical isolates from Korea. Antimicrob Agents Chemother 49 (2005) 4485-4491
3. Hughes A.J., Ariffin N., Huat T.L., Abdul Molok H., Hashim S., Sarijo J., et al. Prevalence of nosocomial infection and antibiotic use at a university medical center in Malaysia. Infect Control Hosp Epidemiol 26 (2005) 100-104
4. Lee H.J., Suh J.T., Kim Y.S., Lenz W., Bierbaum G., and Schaal K.P. Typing and antimicrobial susceptibilities of methicillin-resistant Staphylococcus aureus (MRSA) strains isolated in a hospital in Korea. J Korean Med Sci 16 (2001) 381-385
5. Thongpiyapoom S., Narong M.N., Suwalak N., Jamulitrat S., Intaraksa P., Boonrat J., et al. Device-associated infections and patterns of antimicrobial resistance in a medical-surgical intensive care unit in a university hospital in Thailand. J Med Assoc Thai 87 (2004) 819-824
6. Lim T.K. Emerging pathogens for pneumonia in Singapore. Ann Acad Med Singapore 26 (1997) 651-658
7. Diekema D.J., Pfaller M.A., Schmitz F.J., Smayevsky J., Bell J., Jones R.N., et al., SENTRY Partcipants Group. Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis 32 Suppl 2 (2001) S114-S132
8. Kim H.B., Park W.B., Lee K.D., Choi Y.J., Park S.W., Oh M.D., et al. Nationwide surveillance for Staphylococcus aureus with reduced susceptibility to vancomycin in Korea. J Clin Microbiol 41 (2003) 2279-2281
9. Hsueh P.R., Liu C.Y., and Luh K.T. Current status of antimicrobial resistance in Taiwan. Emerg Infect Dis 8 (2002) 132-137
10. Hsueh P.R., Liu Y.C., Yang D., Yan J.J., Wu T.L., Huang W.K., et al. Multicenter surveillance of antimicrobial resistance of major bacterial pathogens in intensive care units in 2000 in Taiwan. Microb Drug Resist 7 (2001) 373-382
11. Lee K., Park K.H., Jeong S.H., Lim H.S., Shin J.H., Yong D., et al. Further increase of vancomycin-resistant Enterococcus faecium, amikacin- and fluoroquinolone-resistant Klebsiella pneumoniae, and imipenem-resistant Acinetobacter species in Korea: 2003 KONSAR surveillance. Yonsei Med J 47 (2006) 43-54
12. Lee K., Kim Y.A., Park Y.J., Lee H.S., Kim M.Y., Kim E.-C., et al. Increasing prevalence of vancomycin-resistant enterococci, and cefoxitin-, imipenem- and fluoroquinolone-resistant gram-negative bacilli: a KONSAR Study in 2002. Yonsei Med J 45 (2004) 598-608
13. Bell J.M., and Turnidge J.D. High prevalence of oxacillin-resistant Staphylococcus aureus isolates from hospitalized patients in Asia-Pacific and South Africa: results from SENTRY Antimicrobial Surveillance Program, 1998-1999. Antimicrob Agents Chemother 46 (2002) 879-881
14. Ip M.D., Lyon D.J., Chio F., and Cheng A.F. A longitudinal analysis of methicillin-resistant Staphylococcus aureus in a Hong Kong teaching hospital. Infect Control Hosp Epidemiol 25 (2004) 126-129
15. Carlos C.C. The 2004 Antimicrobial resistance surveillance data in the Philippines. Phil J Microbiol Infect Dis 34 (2005) 53-57
16. Rajaduraipandi K., Mani K.R., Panneerselvam K., Mani M., Bhaskar M., and Manikandan P. Prevalence and antimicrobial susceptibility pattern of methicillin-resistant Staphylococcus aureus: a multicentre study. Indian J Med Microbiol 24 (2006) 34-38
17. Hafiz S., Hafiz A.N., Ali L., Chughtai A.S., Memon B., Ahmed A., et al. Methicillin-resistant Staphylococcus aureus: a multicenter study. J Pak Med Assoc 52 (2002) 312-315
18. Linares J. The VISA/GISA problem: therapeutic implications. Clin Microbiol Infect 7 Suppl 4 (2001) 8-15
19. Trakulsomboon S., Danchaivijtr S., Rongrungruang Y., Dhiraputra C., Susaemgrat W., Ito T., et al. First report of methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycin in Thailand. J Clin Microbiol 39 (2001) 591-595
20. Lulitanond A., Chanawong A., Sribenjalux P., Kaewkes W., Charoensri N., Leumsai D., et al. Occurrence of methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycin in Srinagarind Hospital. J Infect Dis Antimicrob Agents 22 (2005) 9-14
21. Phongsamart W., Sriefungfung S., Tiensasitorn C., Vanprapar N., Chearskul S., and Chokephaibulkit K. The first pediatric case of Staphylococcus aureus with heterogenous resistant to vancomycin endocarditis in Thailand. J Med Assoc Thai 88 Suppl 8 (2005) S264-S268
22. Song J.H., Hirmatsu K., Suh J.Y., Ko K.S., Ito T., Kapi M., et al., Asian Network for Surveillance of Resistant Pathogens (ANSORP) Study Group. Emergence in Asian countries of Staphylococcus aureus with reduced susceptibility to vancomycin. Antimicrob Agents Chemother 48 (2004) 4926-4928
23. Kim H.B., Lee Y.S., Kim B.S., Cha J.O., Kwon S.U., Lee H.J., et al. Prevalence and clinical implications of Staphylococcus aureus with a vancomycin MIC of 4 mcg/mL in Korea. Microb Drug Resist 12 (2006) 33-38
24. Petdachai W. Nosocomial pneumonia in a newborn intensive care unit. J Med Assoc Thai 83 (2000) 392-397
25. Suri A., Mahapatra A.K., and Kapil A. Acinetobacter infection in neurosurgical intensive care patients. Natl Med J India 13 (2000) 296-300
26. Singh A.K., Sen M.R., Anapurba S., and Bhattacharya P. Antibiotic sensitivity pattern of the bacteria isolated from nosocomial infections in ICU. J Commun Dis 34 (2002) 257-263
27. Garnacho-Montero J., Ortiz-Leyba C., Jimenez-Jimenez F.J., Barrero-Almodovar A.E., Garcia-Garmendia J.L., Bernabeu-Wittell M., et al. Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP. Clin Infect Dis 36 (2003) 1111-1118
28. Falagas M.E., Kasiakou S.K., Tsiodras S., and Michalopoulos A. The use of intravenous and aerosolized polymyxins for the treatment of infections in critically ill patients: a review of the recent literature. Clin Med Res 4 (2006) 138-146
29. Lee K., Ha G.Y., Shin B.M., Kim J.J., Kang J.O., Jang S.J., et al. Metallo-β-lactamase-producing gram-negative bacilli in Korean Nationwide Surveillance of Antimicrobial Resistance group hospitals in 2003: continued prevalence of VIM-producing Pseudomonas spp. and increase of IMP-producing Acinetobacter spp. Diagn Microbiol Infect Dis 50 (2004) 51-58
30. Yu Y.S., Yang Q., Xu X.W., Hs K., Xu G.Y., and Zhong B.Y. Typing and characterization of carbapenem-resistant Acinetobacter calcoaceticus-baumannii complex in a Chinese hospital. J Med Microbiol 53 (2004) 653-656
31. Johnson D.M., Biedenbach D.J., and Jones R.N. In vitro evaluation of broad-spectrum β-lactams in the Philippines medical centers: role of fourth-generation cephalosporins. The Philippines Antimicrobial Resistance Study Group. Diagn Microbiol Infect Dis 35 (1999) 291-297
32. Grover S.S., Sharma M., Pasha S.T., Singh G., and Lal S. Antimicrobial susceptibility pattern and prevalence of extended spectrum β-lactamase (ESBLs) producing strains of Klebsiella pneumoniae from a major hospital in New Delhi. J Commun Dis 36 (2004) 17-26
33. Jain A., Roy I., Gupta M.K., Kumar M., and Agarwal S.K. Prevalence of extended-spectrum β-lactamase-producing gram-negative bacteria in septicaemic neonates in a tertiary carehospital. J Med Microbiol 52 (2003) 421-425
34. Jitsurong S., and Yodsawat J. Prevalence of extended-spectrum β-lactamases (ESBLs) produced in blood isolates of gram-negative bacteria in a teaching hospital in southern Thailand. Southeast Asian J Trop Med Public Health 37 (2006) 131-135
35. Chayakulkeeree M., Junsriwong P., Keerasuntonpong A., Tribuddharat C., and Thamlikitkul V. Epidemiology of extended-spectrum β-lactamase producing gram-negative bacilli in Siriraj Hyospital, Thailand, 2003. Southeast Asian J Trop Med Public Health 36 (2005) 1503-1509
36. Chen M.J., Wang H., and China Nosocomial Pathogens Resistance Surveillance Study Group. Continuous surveillance of antimicrobial resistance among nosocomial gram-negative bacilli from intensive care units in China (article in Chinese). Zhonghua Yi Xue Za Zhi 10 (2003) 375-381
37. Ho P.L., Tsang D.N., Que T.L., Ho M., and Yuen K.Y. Comparison of screening methods for detection of extended-spectrum β-lactamases and their prevalence among Escherichia coli and Klebsiella species in Hong Kong. APMIS 108 (2000) 237-240
38. Hirakata Y., Matsuda J., Miyazaki Y., Kamihira S., Kawakami S., Miyazawa Y., et al. Regional variation in the prevalence of extended-spectrum β-lactamase-producing clinical isolates in the Asia-Pacific region (SENTRY 1998-2002). Diagn Microbiol Infect Dis 52 (2005) 323-329
39. Jabeen K., Zafar A., and Hasan R. Frequency and sensitivity pattern of extended spectrum β-lactamase-producing isolates in a tertiary care hospital laboratory of Pakistan. J Pak Med Asoc 55 (2005) 436-439
40. Jones R.N., Rhomberg P.R., Varnam D.J., and Mathai D. A comparison of the antimicrobial activity of meropenem and selected broad-spectrum antimicrobials tested against multi-drug resistant gram-negative bacilli including bacteraemic Salmonella spp.: initial studies for the MYSTIC programme in India. Int J Antimicrob Agents 20 (2002) 426-431
41. Liao C.H., Sheng W.H., Want J.T., Sun H.Y., Wang H.K., Hsueh P.R., et al. In vitro activities of 16 antimicrobial agents against clinical isolates of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in two regional hospitals in Taiwan. J Microbiol Immunol Infect 39 (2006) 59-66
42. Wang H., Chen M., and China Nosocomial Pathogens Resistance Surveillance Group. Surveillance for antimicrobial resistance among clinical isolates of gram-negative bacteria from intensive care unit patients in China, 1996 to 2002. Diagn Microbiol Infect Dis 51 (2005) 201-208
43. Girlich D., Naas T., Leelaporn A., Poirel L., Fennewald M., and Nordmann P. Nosocomial spread of the integron-located veb-1-like cassette encoding an extended-spectrum β-lactamase in Pseudomonas aeruginosa in Thailand. Clin Infect Dis 34 (2002) 603-611